• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中朊病毒假说:从 Braak 到未来。

The prion hypothesis in Parkinson's disease: Braak to the future.

机构信息

Division of Patient Based Clinical Research, Toronto Western Research Institute, and the Edmond J, Safra Program in Parkinson's Disease, Toronto Western Hospital, McLaughlin Pavilion, 7th Floor Rm 7-403, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.

出版信息

Acta Neuropathol Commun. 2013 May 8;1:2. doi: 10.1186/2051-5960-1-2.

DOI:10.1186/2051-5960-1-2
PMID:24252164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3776210/
Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder typified by the presence of intraneuronal inclusions containing aggregated alpha synuclein (αsyn). The progression of parkinsonian pathology and clinical phenotype has been broadly demonstrated to follow a specific pattern, most notably described by Braak and colleagues. In more recent times it has been hypothesized that αsyn itself may be a critical factor in mediating transmission of disease pathology from one brain area to another. Here we investigate the growing body of evidence demonstrating the ability of αsyn to spread transcellularly and induce pathological aggregation affecting neurons by permissive templating and provide a critical analysis of some irregularities in the hypothesis that the progression of PD pathology may be mediated by such a prion-like process. Finally we discuss some key questions that remain unanswered which are vital to determining the potential contribution of a prion-like process to the pathogenesis of PD.

摘要

帕金森病(PD)是一种进行性神经退行性疾病,其特征是存在含有聚集的α-突触核蛋白(αsyn)的神经元内包涵体。帕金森病病理和临床表型的进展已被广泛证明遵循特定模式,最著名的是由 Braak 及其同事描述的模式。最近有人假设,αsyn 本身可能是介导疾病病理从一个脑区传播到另一个脑区的关键因素。在这里,我们研究了越来越多的证据,这些证据表明 αsyn 具有通过允许模板形成而进行细胞间传播并诱导影响神经元的病理性聚集的能力,并对该假说的一些不规则性进行了批判性分析,即 PD 病理的进展可能是由这种类朊病毒样过程介导的。最后,我们讨论了一些仍然没有答案的关键问题,这些问题对于确定类朊病毒样过程对 PD 发病机制的潜在贡献至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/3776210/fff8d3bd98ef/2051-5960-1-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/3776210/6ca6dbdbb38a/2051-5960-1-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/3776210/fff8d3bd98ef/2051-5960-1-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/3776210/6ca6dbdbb38a/2051-5960-1-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f51e/3776210/fff8d3bd98ef/2051-5960-1-2-2.jpg

相似文献

1
The prion hypothesis in Parkinson's disease: Braak to the future.帕金森病中朊病毒假说:从 Braak 到未来。
Acta Neuropathol Commun. 2013 May 8;1:2. doi: 10.1186/2051-5960-1-2.
2
The Neural Gut-Brain Axis of Pathological Protein Aggregation in Parkinson's Disease and Its Counterpart in Peroral Prion Infections.帕金森病病理性蛋白聚集的神经-肠道-脑轴及其在经口朊病毒感染中的对应物。
Viruses. 2021 Jul 18;13(7):1394. doi: 10.3390/v13071394.
3
The concept of alpha-synuclein as a prion-like protein: ten years after.α-突触核蛋白作为类朊病毒蛋白的概念:十年之后。
Cell Tissue Res. 2018 Jul;373(1):161-173. doi: 10.1007/s00441-018-2814-1. Epub 2018 Feb 26.
4
Prying into the Prion Hypothesis for Parkinson's Disease.探究帕金森病的朊病毒假说
J Neurosci. 2017 Oct 11;37(41):9808-9818. doi: 10.1523/JNEUROSCI.1788-16.2017.
5
Parkinson's Disease Is Not Simply a Prion Disorder.帕金森病并非简单的朊病毒病。
J Neurosci. 2017 Oct 11;37(41):9799-9807. doi: 10.1523/JNEUROSCI.1787-16.2017.
6
Predictive model of spread of Parkinson's pathology using network diffusion.利用网络扩散预测帕金森病病理扩散的模型。
Neuroimage. 2019 May 15;192:178-194. doi: 10.1016/j.neuroimage.2019.03.001. Epub 2019 Mar 6.
7
[Is Parkinson's disease a prion disease?].[帕金森病是一种朊病毒病吗?]
Rev Neurol (Paris). 2015 Dec;171(12):812-24. doi: 10.1016/j.neurol.2015.10.005. Epub 2015 Nov 10.
8
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.14-3-3 蛋白减少致病性 α-突触核蛋白的细胞间转移和传播。
J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9.
9
Gangliosides, α-Synuclein, and Parkinson's Disease.神经节苷脂、α-突触核蛋白与帕金森病。
Prog Mol Biol Transl Sci. 2018;156:435-454. doi: 10.1016/bs.pmbts.2017.12.009. Epub 2018 Feb 24.
10
How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology.帕金森病是如何开始的?神经解剖途径、朊病毒和组织学的观点。
Mov Disord. 2018 Jan;33(1):48-57. doi: 10.1002/mds.27138. Epub 2017 Aug 26.

引用本文的文献

1
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
2
The interplay between α-synuclein aggregation and necroptosis in Parkinson's disease: a spatiotemporal perspective.帕金森病中α-突触核蛋白聚集与坏死性凋亡之间的相互作用:时空视角
Front Neurosci. 2025 Apr 8;19:1567445. doi: 10.3389/fnins.2025.1567445. eCollection 2025.
3
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's disease.

本文引用的文献

1
Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.厘清帕金森病中路易小体与黑质神经元丢失之间的关系。
J Parkinsons Dis. 2011;1(3):277-86. doi: 10.3233/JPD-2011-11046.
2
Signs of degeneration in 12-22-year old grafts of mesencephalic dopamine neurons in patients with Parkinson's disease.帕金森病患者中脑多巴胺神经元移植物 12-22 岁时的退变迹象。
J Parkinsons Dis. 2011;1(1):83-92. doi: 10.3233/JPD-2011-11004.
3
α-Synuclein oligomers and clinical implications for Parkinson disease.α-突触核蛋白寡聚物与帕金森病的临床意义。
需要一种个性化且全面的方法来抑制或补充帕金森病中的α-突触核蛋白(SNCA)。
NPJ Parkinsons Dis. 2025 Mar 4;11(1):42. doi: 10.1038/s41531-025-00887-3.
4
Mitochondrial Dysfunction as a Potential Mechanism Mediating Cardiac Comorbidities in Parkinson's Disease.线粒体功能障碍作为介导帕金森病心脏合并症的潜在机制。
Int J Mol Sci. 2024 Oct 12;25(20):10973. doi: 10.3390/ijms252010973.
5
Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways.神经退行性疾病中的错误折叠和聚集:蛋白质质量控制机制作为潜在的治疗性清除途径。
Cell Commun Signal. 2024 Aug 30;22(1):421. doi: 10.1186/s12964-024-01791-8.
6
Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins.探索人类突触核蛋白和相关蛋白中的内源性无序。
Int J Mol Sci. 2024 Aug 1;25(15):8399. doi: 10.3390/ijms25158399.
7
Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application.肠-脑轴:一种针对神经疾病的前沿方法及潜在的合生元应用。
Heliyon. 2024 Jul 4;10(13):e34092. doi: 10.1016/j.heliyon.2024.e34092. eCollection 2024 Jul 15.
8
Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease.聚焦肠脑轴:多酚、微生物群及其对帕金森病中α-突触核蛋白的影响。
Nutrients. 2024 Jun 27;16(13):2041. doi: 10.3390/nu16132041.
9
Broad proteomics analysis of seeding-induced aggregation of α-synuclein in M83 neurons reveals remodeling of proteostasis mechanisms that might contribute to Parkinson's disease pathogenesis.M83 神经元中 α-突触核蛋白诱导聚集的广泛蛋白质组学分析揭示了可能导致帕金森病发病机制的蛋白质稳态机制的重塑。
Mol Brain. 2024 May 22;17(1):26. doi: 10.1186/s13041-024-01099-1.
10
From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?从肠道到大脑:肠道菌群是帕金森病治疗的新模式吗?
Cells. 2024 Apr 30;13(9):770. doi: 10.3390/cells13090770.
Ann Neurol. 2013 Feb;73(2):155-69. doi: 10.1002/ana.23746. Epub 2012 Dec 7.
4
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice.病理性α-突触核蛋白的传递会在非转基因小鼠中引发类似帕金森病的神经退行性变。
Science. 2012 Nov 16;338(6109):949-53. doi: 10.1126/science.1227157.
5
Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.路易体病理不是帕金森病易损神经元退行性变的最初标志。
Neurology. 2012 Dec 11;79(24):2307-14. doi: 10.1212/WNL.0b013e318278fe32. Epub 2012 Nov 14.
6
Neuron-to-neuron transmission of α-synuclein fibrils through axonal transport.α-突触核蛋白纤维通过轴突运输在神经元间传递。
Ann Neurol. 2012 Oct;72(4):517-24. doi: 10.1002/ana.23747.
7
Spinal cord lesions in sporadic Parkinson's disease.散发性帕金森病的脊髓病变。
Acta Neuropathol. 2012 Nov;124(5):643-64. doi: 10.1007/s00401-012-1028-y. Epub 2012 Aug 29.
8
Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy.抑制动力蛋白 GTP 酶可减少神经元和少突胶质细胞对 α-突触核蛋白的摄取:一种潜在的突触核蛋白病治疗靶点。
Mol Neurodegener. 2012 Aug 14;7:38. doi: 10.1186/1750-1326-7-38.
9
Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo.α-突触核蛋白在体内移植多巴胺能神经元中的细胞间转移和播散。
PLoS One. 2012;7(6):e39465. doi: 10.1371/journal.pone.0039465. Epub 2012 Jun 21.
10
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice.脑内接种病理性 α-突触核蛋白会在小鼠中引发快速进行性神经退行性 α-突触核蛋白病。
J Exp Med. 2012 May 7;209(5):975-86. doi: 10.1084/jem.20112457. Epub 2012 Apr 16.